New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare expenditure. In the United States, approximately 0.1 % of the population experiences an initial VTE event each year. Anticoagulation therapy is the cornerstone of acute VTE treatment and for prevention of recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobesh, Paul P., Fanikos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224738/
https://www.ncbi.nlm.nih.gov/pubmed/25300410
http://dx.doi.org/10.1007/s40265-014-0301-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224738/
https://www.ncbi.nlm.nih.gov/pubmed/25300410
http://dx.doi.org/10.1007/s40265-014-0301-x

Ejemplares similares